Skip to content

The effect of Shock Wave Therapy in patients with Chronic Low Back Pain on pain intensity, muscle strength, functionality, and psychosocial aspects

Effect of Shockwave Therapy on volunteers with Chronic Low Back Pain in the long-term management of physical, clinical-functional, and psychosocial sequelae

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9wddjcd
Enrollment
Unknown
Registered
2025-10-09
Start date
2025-07-12
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Interventions

This is a randomized, controlled, four-arm, blinded clinical trial. The sample will consist of 84 volunteers with mechanical chronic low back pain (CLBP), of both sexes, aged between 18 and 59 years,

Sponsors

Centro de Ciências Biológicas e da Saúde da Universidade Estadual do Oeste do Paraná
Lead Sponsor
Centro de Ciências Biológicas e da Saúde da Universidade Estadual do Oeste do Paraná
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Volunteers of both genders; aged between 18 and 59 years; presenting with persistent and/or recurrent low back pain for more than three months, with physical characteristics compatible with mechanical etiology according to the evaluation and treatment guidelines proposed by the American College of Physicians and the American Pain Society; volunteers recruited from the patient flow of the Unioeste Physical Rehabilitation Center or invited through personalized outreach

Exclusion criteria

Exclusion criteria: Volunteers with non-mechanical low back pain (e.g., cancer-related pain); pregnant women; volunteers with a history of spinal surgery; neurological disorders; volunteers currently undergoing other types of physical therapy interventions

Design outcomes

Primary

MeasureTime frame
To assess kinesiophobia using the Brazilian version of the Tampa Scale for Kinesiophobia, in which the total raw score ranges from 17 to 68 points;To assess self-efficacy using the Brazilian Portuguese validated version of the Chronic Pain Self-Efficacy Scale (CPSS), with scores ranging from 0 to 60;To assess pain qualification using the short-form McGill Pain Questionnaire, which evaluates 15 descriptors, each scored from 0 to 3;To assess the level of disability using the Brazilian version of the Oswestry Disability Index, adapted from the original version 2.0, in which the total score is calculated and expressed as a percentage, classifying the level of disability;To assess pain catastrophizing using the Pain Catastrophizing Scale, which classifies catastrophizing through 13 items, with a total score ranging from 0 to 52;To assess the strength and endurance of trunk extensor muscles using the portable traction dynamometer Dinabang, quantifying strength and endurance in Newtons (N);To assess the tone and biomechanical tissue properties of the paravertebral muscles using the non-invasive tool MyotonPRO;To assess pain intensity using the Visual Analog Scale (VAS), which consists of a 10 cm line on which the patient indicates their level of pain; The closer the mark is to 10, the greater the pain intensity;To assess step frequency, length, and duration, as well as optimal walking speed and the locomotor rehabilitation index through mathematical processing of data from self-selected and maximum walking speeds, both measured during a 10-meter corridor walk, with values expressed in meters per second (m/s);Assessment of functional walking performance based on the distance covered during the Six-Minute Walk Test (6MWT), including monitoring of peripheral oxygen saturation (expressed as a percentage) and heart rate (expressed in beats per minute);To assess direct and indirect measures of strength, as well as dynamic and static stability of the deep pelvic muscles, using th

Secondary

MeasureTime frame
No secondary outcomes are expected

Countries

Brazil

Contacts

Public ContactAlberito Carvalho

Universidade Estadual do Oeste do Paraná - UNIOESTE

alberitorodrigo@gmail.com+55(45)32203132

Outcome results

None listed

Source: REBEC (via WHO ICTRP)